ATCC now offers a complete solution to successfully grow normal human primary mesenchymal stem cells derived from human umbilical cord matrices (Wharton's Jelly).
These can be used for research studies that include developmental biology, regenerative medicine, cell therapy and tissue engineering.
Human Wharton's Jelly-derived stem cells are a non-controversial source of mesenchymal stem cells with unique properties - including high proliferation rates and tumour-homing properties - with important implications for cell-based therapies.
Each lot of ATCC Normal Human Primary Umbilical Cord-Derived Mesenchymal Stem Cells is cryopreserved in the second passage to ensure the highest viability and plating efficiency, and thoroughly tested for sample purity.
They are performance tested together with media, growth supplements and reagents to guarantee reliability as part of ATCC Primary Cell Solutions, a system of matched components designed to maximise growth, maximise functionality and maintain normal morphology for specific cell types.
The complete cell-specific ATCC Primary Cell Solutions growth system (consisting of the Mesenchymal Stem Cell Basal Medium and Growth Kit) creates a suitable cell system culture environment for propagation in low serum (two per cent) conditions and subsequent differentiation.
When maintained under optimal growth conditions, ATCC Normal Human Umbilical Cord-Derived Mesenchymal Stem Cells have been shown to be multipotent, capable of differentiating down the adipogenic, osteogenic and chondrogenic lineages.
New differentiation tools induce chondrocyte or osteocyte differentiation with high efficiency.
The system provides everything a researcher needs to successfully grow the highest quality cultures reliably and consistently - with expert support if needed.
